Umeå University's logo

umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Increased risk of long-term disabilities following childhood bacterial meningitis in Sweden
Center for Observational and Real-World Evidence (CORE), Merck & Co Inc, Rahway, New Jersey, USA.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi, Infektionssjukdomar.ORCID-id: 0000-0001-9885-2321
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk vetenskap, Pediatrik.ORCID-id: 0000-0002-3606-3797
CORE, MSD (Merck Sharpe & Dohme LLC) Sweden, Stockholm, Sweden.
Vise andre og tillknytning
2024 (engelsk)Inngår i: JAMA Network Open, E-ISSN 2574-3805, Vol. 7, nr 1, artikkel-id e2352402Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

IMPORTANCE: Few studies have examined the incidence of long-term disabilities due to bacterial meningitis in childhood with extended follow-up time and a nationwide cohort.

OBJECTIVE: To describe the long-term risks of disabilities following a childhood diagnosis of bacterial meningitis in Sweden.

DESIGN, SETTING, AND PARTICIPANTS: This nationwide retrospective registry-based cohort study included individuals diagnosed with bacterial meningitis (younger than 18 years) and general population controls matched (1:9) by age, sex, and place of residence. Data were retrieved from the Swedish National Patient Register from January 1, 1987, to December 31, 2021. Data were analyzed from July 13, 2022, to November 30, 2023.

EXPOSURE: A diagnosis of bacterial meningitis in childhood recorded in the National Patient Register between 1987 and 2021.

MAIN OUTCOMES AND MEASURES: Cumulative incidence of 7 disabilities (cognitive disabilities, seizures, hearing loss, motor function disorders, visual disturbances, behavioral and emotional disorders, and intracranial structural injuries) after bacterial meningitis in childhood.

RESULTS: The cohort included 3623 individuals diagnosed with bacterial meningitis during childhood and 32 607 controls from the general population (median age at diagnosis, 1.5 [IQR, 0.4-6.2] years; 44.2% female and 55.8% male, median follow-up time, 23.7 [IQR, 12.2-30.4] years). Individuals diagnosed with bacterial meningitis had higher cumulative incidence of all 7 disabilities, and 1052 (29.0%) had at least 1 disability. The highest absolute risk of disabilities was found for behavioral and emotional disorders, hearing loss, and visual disturbances. The estimated adjusted hazard ratios (HRs) showed a significant increased relative risk for cases compared with controls for all 7 disabilities, with the largest adjusted HRs for intracranial structural injuries (26.04 [95% CI, 15.50-43.74]), hearing loss (7.90 [95% CI, 6.68-9.33]), and motor function disorders (4.65 [95% CI, 3.72-5.80]). The adjusted HRs for cognitive disabilities, seizures, hearing loss, and motor function disorders were significantly higher for Streptococcus pneumoniae infection (eg, 7.89 [95% CI, 5.18-12.02] for seizure) compared with Haemophilus influenzae infection (2.46 [95% CI, 1.63-3.70]) or Neisseria meningitidis infection (1.38 [95% CI, 0.65-2.93]). The adjusted HRs for cognitive disabilities, seizures, behavioral and emotional disorders, and intracranial structural injuries were significantly higher for children diagnosed with bacterial meningitis at an age below the median.

CONCLUSIONS AND RELEVANCE: The findings of this cohort study of individuals diagnosed with bacterial meningitis during childhood suggest that exposed individuals may have had an increased risk for long-term disabilities (particularly when diagnosed with pneumococcal meningitis or when diagnosed at a young age), highlighting the need to detect disabilities among surviving children.

sted, utgiver, år, opplag, sider
American Medical Association (AMA), 2024. Vol. 7, nr 1, artikkel-id e2352402
HSV kategori
Forskningsprogram
infektionssjukdomar
Identifikatorer
URN: urn:nbn:se:umu:diva-219872DOI: 10.1001/jamanetworkopen.2023.52402ISI: 001145726200005PubMedID: 38241045Scopus ID: 2-s2.0-85182833206OAI: oai:DiVA.org:umu-219872DiVA, id: diva2:1830364
Tilgjengelig fra: 2024-01-23 Laget: 2024-01-23 Sist oppdatert: 2024-04-10bibliografisk kontrollert

Open Access i DiVA

fulltext(1082 kB)185 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 1082 kBChecksum SHA-512
ca21cba34c060a95229c2d0cb8d50259d1616841768c4a22f6956309c62ed3176519291c552f31edf4ebff360a179cdadb0429d5998b6388b0830b0688330644
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Johansson Kostenniemi, UrbanSilfverdal, Sven-Arne

Søk i DiVA

Av forfatter/redaktør
Johansson Kostenniemi, UrbanSilfverdal, Sven-Arne
Av organisasjonen
I samme tidsskrift
JAMA Network Open

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 185 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 509 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf